Emergent BioSolutions Inc. EBS
NYSE · United States · Health Technology
$6.33-0.04 (-0.63%)
Market closed· · USD · Data may be delayed
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | 0.60 | -0.09 | +805.9% | $234.30M | +32.0% | -29.9%$7.57→$5.31 |
| Q1 2026 | 2026-04-30 | 0.21 | -0.25 | +184.0% | — | — | +6.0%$7.99→$8.47 |
| Q4 2025 | 2026-02-26 | -0.43 | — | — | — | — | -26.0%$11.01→$8.15 |
| Q3 2025 | 2025-10-29 | 1.06 | -0.12 | +983.3% | — | — | +35.6%$9.47→$12.84 |
| Q4 2024 | 2025-03-03 | 0.05 | -0.50 | +110.0% | — | — | — |
| Q4 2023 | 2024-03-06 | -0.77 | -0.32 | -140.6% | — | — | — |
| Q3 2023 | 2023-12-11 | -5.08 | -0.54 | -840.7% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.